z-logo
open-access-imgOpen Access
Successful Utilization of High-Flux Hemodialysis for Treatment of Vancomycin Toxicity in a Child
Author(s) -
Timothy Stidham,
Pamela D. Reiter,
Douglas M. Ford,
Gary M. Lum,
Joseph Albietz
Publication year - 2011
Publication title -
case reports in pediatrics
Language(s) - English
Resource type - Journals
eISSN - 2090-6803
pISSN - 2090-6811
DOI - 10.1155/2011/678724
Subject(s) - vancomycin , medicine , toxicity , hemodialysis , dosing , antibiotics , adverse effect , intensive care medicine , renal function , staphylococcus aureus , microbiology and biotechnology , biology , bacteria , genetics
Vancomycin is routinely used for empiric antibiotic therapy in children. Higher-serum-concentration targets for serious infections are now being recommended. This recommendation may result in aggressive dosing with increased potential for toxicity. We report a case of a pediatric patient who developed vancomycin toxicity and associated oliguric renal failure who was treated effectively with high-flux hemodialysis for vancomycin toxicity, clearing serum concentrations of vancomycin by over 75% in only 6 hours (213.2 mcg/mL to 51.8 mcg/mL) with subsequent return to baseline renal function and without adverse sequelae. While not historically considered a viable option for drug removal in cases of toxicity, new high-flux hemodialysis techniques can remove significant percentages of vancomycin in short periods of time.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom